ACIM
ABBV icon

Azimuth Capital Investment Management’s AbbVie ABBV Stock Holding History

Azimuth Capital Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5M Sell
101,361
-511
-0.5% -$110K 0.86% 23
2026
Q1 		$22.2M Sell
101,872
-4,751
-4% -$1.05M 0.83% 26
2025
Q4 		$24.4M Sell
106,623
-573
-0.5% -$131K 0.87% 22
2025
Q3 		$24.8M Sell
107,196
-2,081
-2% -$424K 0.89% 26
2025
Q2 		$20.3M Buy
109,277
+1,179
+1% +$219K 0.75% 38
2025
Q1 		$22.6M Buy
108,098
+339
+0.3% +$65.9K 0.9% 27
2024
Q4 		$19.1M Buy
107,759
+6,388
+6% +$1.17M 0.74% 40
2024
Q3 		$20M Buy
101,371
+1,309
+1% +$244K 0.78% 35
2024
Q2 		$17.2M Buy
100,062
+13,750
+16% +$2.28M 0.7% 43
2024
Q1 		$15.7M Sell
86,312
-354
-0.4% -$61K 0.65% 51
2023
Q4 		$13.4M Sell
86,666
-2,310
-3% -$337K 0.61% 56
2023
Q3 		$13.3M Buy
88,976
+587
+0.7% +$86.2K 0.65% 48
2023
Q2 		$11.9M Sell
88,389
-10,446
-11% -$1.53M 0.57% 58
2023
Q1 		$15.8M Sell
98,835
-2,058
-2% -$315K 0.78% 33
2022
Q4 		$16.3M Sell
100,893
-2,354
-2% -$361K 0.83% 31
2022
Q3 		$13.9M Sell
103,247
-4,474
-4% -$642K 0.76% 37
2022
Q2 		$16.5M Buy
+107,721
New +$16.5M 0.83% 27

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Azimuth Capital Investment Management's ABBV Position: Q2 2026 in Review

Azimuth Capital Investment Management reduced its AbbVie (ABBV) stake by 0.5% in Q2 2026, selling an estimated $110K and leaving 101,361 shares worth $25.5M. The position accounts for 0.86% of the portfolio, ranked #23.

Azimuth Capital Investment Management first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Azimuth Capital Investment Management held 101,361 shares of AbbVie worth $25.5M as of Q2 2026.
  • Azimuth Capital Investment Management sold 511 AbbVie shares in Q2 2026, an estimated $110K.
  • AbbVie made up 0.86% of Azimuth Capital Investment Management's portfolio in Q2 2026, its #23 holding.
  • Azimuth Capital Investment Management first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.